Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vitaly Balan

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
The CRISPR System and Cancer Immunotherapy BiomarkersVitaly Balan, Jianbin Wang
Methods in Enzymology|March 4, 2020
CRISPR technology for immuno-oncology applicationsJianbin Wang, Vitaly Balan, Francesco Marincola
Journal of Translational Medicine|February 3, 2026
Computational modelling and network medicine in drug toxicology and clinical pharmacovigilanceQi Zhao, Xiao Li, Vitaly Balan
Cancer Metastasis Reviews|September 15, 2020
Galectin-3: an immune checkpoint target for musculoskeletal tumor patientsKosei Nakajima, Vitaly Balan, Avraham Raz
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|March 25, 2009
Regulation of tumor progression by extracellular galectin-3Pratima Nangia-Makker, Vitaly Balan, Avraham Raz
Cancers|May 10, 2013
Galectins as cancer biomarkersVitaly Balan, Pratima Nangia-Makker, Avraham Raz
Methods in Molecular Biology (Clifton, N.J.)|June 8, 2012
Galectin-3 binding and metastasisPratima Nangia-Makker, Vitaly Balan, Avraham Raz
Oncotarget|May 10, 2014
Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathwayXiaoge Gao, Vitaly Balan, Guihua Tai, et al.
Seminars in Cancer Biology|May 27, 2006
14-3-3 proteins as potential oncogenesGuri Tzivion, Vinita Singh Gupta, Ludmila Kaplun, et al.
The Journal of Biological Chemistry|October 22, 2022
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseasesPratima Nangia-Makker, Victor Hogan, Vitaly Balan, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
The CRISPR System and Cancer Immunotherapy BiomarkersVitaly Balan, Jianbin Wang
Methods in Enzymology|March 4, 2020
CRISPR technology for immuno-oncology applicationsJianbin Wang, Vitaly Balan, Francesco Marincola
Journal of Translational Medicine|February 3, 2026
Computational modelling and network medicine in drug toxicology and clinical pharmacovigilanceQi Zhao, Xiao Li, Vitaly Balan
Cancer Metastasis Reviews|September 15, 2020
Galectin-3: an immune checkpoint target for musculoskeletal tumor patientsKosei Nakajima, Vitaly Balan, Avraham Raz
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|March 25, 2009
Regulation of tumor progression by extracellular galectin-3Pratima Nangia-Makker, Vitaly Balan, Avraham Raz
Cancers|May 10, 2013
Galectins as cancer biomarkersVitaly Balan, Pratima Nangia-Makker, Avraham Raz
Methods in Molecular Biology (Clifton, N.J.)|June 8, 2012
Galectin-3 binding and metastasisPratima Nangia-Makker, Vitaly Balan, Avraham Raz
Oncotarget|May 10, 2014
Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathwayXiaoge Gao, Vitaly Balan, Guihua Tai, et al.
Seminars in Cancer Biology|May 27, 2006
14-3-3 proteins as potential oncogenesGuri Tzivion, Vinita Singh Gupta, Ludmila Kaplun, et al.
The Journal of Biological Chemistry|October 22, 2022
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseasesPratima Nangia-Makker, Victor Hogan, Vitaly Balan, et al.
Pageof 4